OSL:CRNA - Euronext Oslo - NO0013033795 - Common Stock - Currency: NOK
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 123.00K | 10.00M | 0.00 | 620.00K | |||
Operating Expenses | 42.49M | 100.09M | 503.59M | 95.98M | 104.53M | |||
Research and Development | 27.61M | 70.03M | 77.63M | 63.27M | 69.11M | |||
Selling, General, and Administrative Expenses | 10.90M | 16.34M | 25.84M | 25.86M | 20.99M | |||
Operating Income | -42.49M | -99.97M | -493.59M | -95.98M | -103.90M | |||
Interest Income/Expense | 42.00K | -2.02M | -1.64M | -720.00K | -390.00K | |||
Other Income/Expense | 99.97M | -10.96M | -100.00K | -1.70M | -4.12M | |||
Non Recurring Items | N/A | N/A | 0.00 | 380.00K | N/A | |||
Income Before Taxes | 57.52M | -112.94M | -495.33M | -98.02M | -108.40M | |||
Income Tax | 0.00 | 0.00 | -62.43M | -50.00K | -280.00K | |||
Net Income | 57.52M | -112.94M | -432.90M | -97.97M | -108.13M | |||
EBITDA | N/A | -98.19M | -100.92M | -94.67M | -100.16M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 2.79 | -16.65 | -2.30 | -1.10 | -1.00 | |||
Non GAAP EPS | N/A | N/A | N/A | -8.99 | -1.00 | |||
Statistics | ||||||||
Profit Margin | N/A | -91821.95% | -4329.00% | N/A | -17440.32% | |||
Operating Profit Margin | N/A | -81272.36% | -4935.90% | N/A | -16758.06% |
All data in NOK